Holdings
Redmile Group, LLC
As of Sep 30, 2026, Redmile Group, LLC reported 43 positions worth US$1.35B. Largest: Nurix Therapeutics, Inc., Krystal Biotech, Inc. and Scholar Rock Holding Corporation. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Nurix Therapeutics, Inc. | 7.9M | US$187M | +3.83M | Sep 30, 2026 |
| Krystal Biotech, Inc. | 528K | US$175M | −104K | Sep 30, 2026 |
| Scholar Rock Holding Corporation | 3.03M | US$147M | −1.28M | Sep 30, 2026 |
| Stoke Therapeutics, Inc. | 3.87M | US$101M | −76,892 | Sep 30, 2026 |
| Immunome, Inc. | 4.36M | US$93.8M | −549K | Sep 30, 2026 |
| Absci Corporation | 6.67M | US$71.9M | −68,298 | Sep 30, 2026 |
| Electra Therapeutics, Inc. | 5.43M | US$61.1M | new | Sep 30, 2026 |
| Annexon, Inc. | 14.3M | US$60.4M | +2.41M | Sep 30, 2026 |
| Neurogene Inc. | 1.56M | US$43.5M | +150K | Sep 30, 2026 |
| Regenxbio Inc. | 5.05M | US$38M | +680K | Sep 30, 2026 |